Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - domperidone, quantity: 10 mg - tablet, film coated - excipient ingredients: magnesium stearate; pregelatinised potato starch; povidone; sodium lauryl sulfate; maize starch; hypromellose; lactose monohydrate; hydrogenated cottonseed oil; microcrystalline cellulose - for the short term treatment in adults of: 1. symptoms associated with idiopathic or diabetic gastroparesis(once control of diabetes has been established by diet and/or insulin, attempt should be made to discontinue motilium) 2. intractable nausea and vomiting from any cause.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

natco pharma limited - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron hydrochloride tablets usp are indicated for the prevention of: nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation. granisetron hydrochloride is contraindicated in patients with known hypersensitivity to the drug or any of its components.

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - granisetron hydrochloride - film coated tablet - 1 milligram

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

rex medical ltd - granisetron hydrochloride 1.12mg equivalent to 1.0 mg granisetron base - film coated tablet - 1 mg - active: granisetron hydrochloride 1.12mg equivalent to 1.0 mg granisetron base excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry white 04f58804 purified water   sodium starch glycolate - granisetron is indicated for the prevention of acute and delayed nausea and vomiting associated with cytostatic therapy

Stati Uniti - Ingliż - NLM (National Library of Medicine)

northstar rx llc - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron hydrochloride tablets are indicated for the prevention of: - nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. - nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation. granisetron hydrochloride is contraindicated in patients with known hypersensitivity to the drug or any of its components.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

bionpharma inc. - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron hydrochloride tablets are indicated for the prevention of: - nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. - nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation. granisetron hydrochloride is contraindicated in patients with known hypersensitivity to the drug or any of its components.

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - granisetron hydrochloride - film coated tablet - 2 milligram

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

arrow generics limited - ondansetron - film coated tablet - 4 milligram

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

arrow generics limited - ondansetron - film coated tablet - 8 milligram

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

imbat limited - ondansetron - film coated tablet - 8 milligram - serotonin (5ht3) antagonists